Paris, France and Camberley, UK – 20 March 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to provide an update regarding the novel coronavirus (COVID-19) test developed by Primerdesign, its molecular diagnostics division based in the UK. http://novacyt.com/wp-content/uploads/2020/03/Novacyt-Covid-19-test-update-ENGLISH-20.03.20-Final.pdf
Visit PageCategory: Uncategorized
Coronavirus test update Initial orders from Public Health England
Paris, France and Camberley, UK – 16 March 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to provide an update regarding the novel coronavirus (COVID-19) test developed by Primerdesign, its molecular diagnostics division. http://novacyt.com/wp-content/uploads/2020/03/Novacyt-Covid-19-test-update-ENGLISH-16.03.20.pdf
Visit PageMise à jour sur le test pour le coronavirus Première commande de Public Health England
Paris, France et Camberley, Royaume-Uni – 16 mars 2020 – Novacyt (ALTERNEXT : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique, a le plaisir d’annoncer de nouveaux développements pour son test pour le nouveau coronavirus (COVID-19) développé par Primerdesign, sa division de diagnostic moléculaire. http://novacyt.com/wp-content/uploads/2020/03/Novacyt-mise-à-jour-sur-le-test-pour-le-coronavirus-FRENCH-16.03.20.pdf
Visit Page